111 related articles for article (PubMed ID: 18932044)
1. Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angiogenesis.
Albertsson P; Lennernäs B; Norrby K
Acta Oncol; 2009; 48(3):418-25. PubMed ID: 18932044
[TBL] [Abstract][Full Text] [Related]
2. Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A.
Albertsson P; Lennernäs B; Norrby K
Acta Oncol; 2008; 47(2):293-300. PubMed ID: 18210302
[TBL] [Abstract][Full Text] [Related]
3. On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A.
Albertsson P; Lennernäs B; Norrby K
Acta Oncol; 2006; 45(2):144-55. PubMed ID: 16546859
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor and de novo mammalian angiogenesis.
Norrby K
Microvasc Res; 1996 Mar; 51(2):153-63. PubMed ID: 8778571
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H
Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative study.
Lennernäs B; Albertsson P; Damber JE; Norrby K
APMIS; 2004 Mar; 112(3):201-9. PubMed ID: 15153162
[TBL] [Abstract][Full Text] [Related]
7. An adenovirus-mediated gene-transfer model of angiogenesis in rat mesentery.
Wang WY; Whittles CE; Harper SJ; Bates DO
Microcirculation; 2004 Jun; 11(4):361-75. PubMed ID: 15280075
[TBL] [Abstract][Full Text] [Related]
8. Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo.
Norrby K
J Vasc Res; 2004; 41(4):293-304. PubMed ID: 15192265
[TBL] [Abstract][Full Text] [Related]
9. VEGF-mediated inflammation precedes angiogenesis in adult brain.
Croll SD; Ransohoff RM; Cai N; Zhang Q; Martin FJ; Wei T; Kasselman LJ; Kintner J; Murphy AJ; Yancopoulos GD; Wiegand SJ
Exp Neurol; 2004 Jun; 187(2):388-402. PubMed ID: 15144865
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1-alpha and de novo mammalian angiogenesis.
Norrby K
Microvasc Res; 1997 Jul; 54(1):58-64. PubMed ID: 9245645
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
12. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
13. [Experimental studies on the optimal therapeutic mode of intra-arterial infusion of 5-fluorouracil. (1) Preparation of an animal model for continuous intra-arterial infusion and comparison of the therapeutic and adverse effects of 5-fluorouracil delivered by various modes].
Ota J
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2353-61. PubMed ID: 6639097
[TBL] [Abstract][Full Text] [Related]
14. The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin.
Damber JE; Vallbo C; Albertsson P; Lennernäs B; Norrby K
Cancer Chemother Pharmacol; 2006 Sep; 58(3):354-60. PubMed ID: 16333676
[TBL] [Abstract][Full Text] [Related]
15. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
[TBL] [Abstract][Full Text] [Related]
16. Contraindications of VEGF-based therapeutic angiogenesis: effects on macrophage density and histology of normal and ischemic brains.
Manoonkitiwongsa PS; Schultz RL; Whitter EF; Lyden PD
Vascul Pharmacol; 2006 May; 44(5):316-25. PubMed ID: 16530019
[TBL] [Abstract][Full Text] [Related]
17. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
Lyons JM; Anthony CT; Thomson JL; Woltering EA
Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy and antiangiogenesis--drug-specific, dose-related effects.
Lennernäs B; Albertsson P; Lennernäs H; Norrby K
Acta Oncol; 2003; 42(4):294-303. PubMed ID: 12899500
[TBL] [Abstract][Full Text] [Related]
19. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical effects of intra-arterial administration of basic fibroblast growth factor on inflammatory angiogenesis in rats.
Foschi D; Corsi F; Cellerino P; Fiume M; Trabucchi E
Drugs Exp Clin Res; 1997; 23(3-4):123-9. PubMed ID: 9403273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
